Published in Clin Exp Immunol on January 01, 1969
The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives. Clin Exp Immunol (1970) 1.76
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (1962) 64.93
A quantitative immunochemical measure of the primary interaction between I BSA and antibody. J Infect Dis (1959) 22.10
Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75
Further experiments on the action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1967) 2.31
Cross-reaction of anti-lymphocyte serum with haemopoietic stem cells. Nature (1968) 1.97
Activity of lymphoid tissues from antilymphocyte-serum-treated mice. Lancet (1967) 1.66
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Some factors influencing the ability of anti-lymphocytic antibody to suppress humoral antibody formation. Clin Exp Immunol (1967) 1.52
Site of action of antilymphocyte globulin. Lancet (1967) 1.51
Effect of anti-rat lymphocyte antibody on humoral antibody formation. Nature (1967) 1.40
Immunological reactivity of lymphoid cells after treatment with anti-lymphocytic serum. Nature (1967) 1.30
The effect of heterologous anti-lymphocyte seerum on mouse hemopoietic stem cells. J Exp Med (1968) 1.07
Suppression of rabbit lymph node cells by rabbit anti-leucocyte serum demonstrated in vitro by the antibody plaque test. J Immunol (1966) 1.04
Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the donor. Clin Exp Immunol (1968) 0.87
In vivo and in vitro effect of anti-lymphocytic IgG on sensitized spleen cells. Nature (1968) 0.86
Effect of F(ab')2 from rabbit anti-mouse lymphocyte IgG on the graft versus host reaction in F1 hybrid mice. Nature (1968) 0.86
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
BioJava: an open-source framework for bioinformatics. Bioinformatics (2008) 6.17
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62
Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75
BCG immunotherapy of bladder cancer: 20 years on. Lancet (1999) 2.38
Human monoclonal antibody production. Current status and future prospects. J Immunol Methods (1987) 2.21
Laboratory staff qualifications and accuracy of proficiency test results. A national study. Arch Pathol Lab Med (1992) 2.07
The natural history of Peyronie's disease. J Urol (1990) 2.02
Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro. Nature (1967) 1.89
Psychotic men remanded in custody to Brixton Prison. Br J Psychiatry (1994) 1.77
Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.72
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer (2003) 1.70
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol (1990) 1.66
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol (1999) 1.63
A genomewide suppressor and enhancer analysis of cdc13-1 reveals varied cellular processes influencing telomere capping in Saccharomyces cerevisiae. Genetics (2008) 1.58
Secretor status, smoking and carriage of Neisseria meningitidis. Epidemiol Infect (1990) 1.55
Some factors influencing the ability of anti-lymphocytic antibody to suppress humoral antibody formation. Clin Exp Immunol (1967) 1.52
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol (2002) 1.50
The preparation and properties of anti-lymphocytic sera. Prog Surg (1969) 1.48
Association between secretor status and respiratory viral illness. BMJ (1991) 1.47
[Surgical treatment of the single non traumatic perforation of small bowel: excision-suture or resection-anastomosis]. Ann Chir (2005) 1.45
Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol (2000) 1.43
Structure-property correlations in a combinatorial library of degradable biomaterials. J Biomed Mater Res (1998) 1.42
Continuous thoracic epidural analgesia versus combined spinal/thoracic epidural analgesia on pain, pulmonary function and the metabolic response following colonic resection. Acta Anaesthesiol Scand (1996) 1.42
Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats. Lancet (1967) 1.41
Effect of anti-rat lymphocyte antibody on humoral antibody formation. Nature (1967) 1.40
Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol (1992) 1.38
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1996) 1.32
The Stonehouse study: secretor status and carriage of Neisseria species. Epidemiol Infect (1989) 1.28
Characterization of antilymphocytic antibody. Nature (1967) 1.27
Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma. J Clin Oncol (1998) 1.27
Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg (1993) 1.26
The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1. Clin Exp Immunol (1983) 1.25
Multiple organ damage caused by a new toxin azaspiracid, isolated from mussels produced in Ireland. Toxicon (2000) 1.23
New allele at cholinesterase locus 1. J Med Genet (1976) 1.20
Secretor state of patients with insulin dependent or non-insulin-dependent diabetes mellitus. Br Med J (Clin Res Ed) (1987) 1.19
Normal and pathological serum levels of alpha2-macroglobulins in men and mice. J Clin Pathol (1975) 1.18
Toxigenic bacteria and sudden infant death syndrome (SIDS): nasopharyngeal flora during the first year of life. FEMS Immunol Med Microbiol (1999) 1.18
Prolongation of canine renal allograft survival with antilymphocytic serum. Transplantation (1968) 1.16
The effect of anti-lymphocytic antibody on the humoral immune response in different strains of mice. I. The response to bovine serum albumin. Immunology (1972) 1.15
Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy. Clin Exp Immunol (1995) 1.14
Flexible eating and flexible insulin dosing in patients with diabetes: Results of an intensive self-management course. Diabetes Res Clin Pract (2008) 1.13
Quantitative studies with antilymphocytic antibody. Nature (1967) 1.13
The antecedents of violence and aggression within psychiatric in-patient settings. Acta Psychiatr Scand (2012) 1.10
Studies on a unique diagnostic serum globulin in papular mucinosis (lichen myxedematosus). Clin Exp Immunol (1967) 1.10
Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study. J Urol (1993) 1.08
Binding of C-reactive protein to human lymphocytes. II. Interaction with a subset of cells bearing the Fc receptor. J Immunol (1981) 1.08
Preliminary observations on the effect of heterologous anti-lymphocytic globulin on autologous immune complex nephritis in rats. Clin Exp Immunol (1969) 1.06
Mechanisms of action of intravesical bacille Calmette-Guérin: local immune mechanisms. Clin Infect Dis (2000) 1.06
Binding of C-reactive protein to human lymphocytes. I. Requirement for a binding specificity. J Immunol (1981) 1.05
Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids. Clin Exp Allergy (2008) 1.05
Distribution of fatty and fibrous plaques in young human coronary arteries. Atherosclerosis (1982) 1.05
Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Mol Immunol (2000) 1.05
A membrane-covered photobacterium probe for oxygen measurements in the nanomolar range. Anal Biochem (1981) 1.04
Prediction of amputation wound healing with skin perfusion pressure. J Vasc Surg (1995) 1.02
Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8. J Clin Oncol (2000) 1.02
The role of bacterial toxins in sudden infant death syndrome (SIDS). Int J Med Microbiol (2002) 1.02
Extracellular organelles (prostasomes) are immunosuppressive components of human semen. Clin Exp Immunol (1991) 1.02
Synovial cells. A study of the morphology and an examination of protein synthesis of synovial cells. Ann Rheum Dis (1966) 1.02
Association of alpha-macroglobulins with lymphoid cells. Nat New Biol (1973) 1.01
Blood group, secretor status and oral carriage of yeasts among patients with diabetes mellitus. Diabetes Res (1989) 1.00
In vitro studies on the heterogeneity of equine antibodies to human lymphoid tissue. Immunochemistry (1969) 1.00
Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes. Immunology (1975) 1.00
The effect of anti-lymphocytic IgG on estab- lished autoallergic thyroiditis in rats. Clin Exp Immunol (1969) 0.99
Dppa3 is a marker of pluripotency and has a human homologue that is expressed in germ cell tumours. Cytogenet Genome Res (2003) 0.99
Community empowerment in the control of lymphatic filariasis in Misima, Milne Bay Province using diethylcarbamazine in combination with albendazole. P N G Med J (2002) 0.99
Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma. Br J Cancer (1976) 0.98
Preliminary studies on the synthesis of alpha2-macroglobulin by human lymphocytes in vitro. Clin Exp Immunol (1974) 0.98
The role of infectious agents in sudden infant death syndrome. FEMS Immunol Med Microbiol (1994) 0.97
The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. 3. The response to type 3 pneumococcus polysaccharide. Immunology (1973) 0.97
Association of host immunoglobulins with solid tumours in vivo. Br J Cancer (1979) 0.97
Lymphocyte sub-populations in the male genital tract. Br J Urol (1985) 0.97
Validation evidence for three coping measures. J Pers Assess (1995) 0.96
The production and characterisation of a panel of ten murine monoclonal antibodies to human procoagulant factor VIII. Thromb Haemost (1986) 0.96
A fluorescence polarization assay for inhibitors of Hsp90. Anal Biochem (2006) 0.96
Detection of pyrogenic toxins of Staphylococcus aureus in sudden infant death syndrome. FEMS Immunol Med Microbiol (1999) 0.96
Characteristics of peritoneal macrophages induced by asbestos injection. Environ Res (1982) 0.95
Prolonged seated immobility at work is a common risk factor for venous thromboembolism leading to hospital admission. Intern Med J (2008) 0.95
Elimination of normal horse IgG labelled with Iodine-131 in rats receiving horse anti-rat lymphocytic IgG. Nature (1967) 0.95
UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. Biochem Biophys Res Commun (1989) 0.94
The association of alpha2-macroglobulin with lymphocyte membranes in chronic lymphocytic leukaemia and other disorders. Clin Exp Immunol (1975) 0.94
The effect of antilymphocytic antibody on the primary immune response of mice to sheep erythrocytes, bovine serum albumin, and type 3 pneumococcus polysaccharide. Transplantation (1971) 0.94
Ileal pouch-anal anastomosis: is preoperative anal manometry predictive of postoperative functional outcome? Dis Colon Rectum (1994) 0.93
The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs. Immunology (2001) 0.93
Strain variations in the primary humoral response of rats and its susceptibility to inhibition by anti-lymphocytic antibody. Nature (1969) 0.92
The immunosuppressive properties of sub-fractions of antilymphocytic IgG of equine origin. Immunology (1971) 0.92
Enhancement of terminal B lymphocyte differentiation in vitro by fibroblast-like stromal cells from human spleen. Eur J Immunol (1998) 0.92
Parallel studies on the effect of anti-lymphocytic antibody on cell mediated and humoral antibody responses in the rat. Clin Exp Immunol (1968) 0.92
Antitumour responses induced by short-term pretreatment with tumour cells. Br J Cancer (1978) 0.92
Trypsin stabilizers in human serum. The role of alpha-2-macroglobulin. Clin Chim Acta (1966) 0.92
Immunosuppression by seminal prostaglandins. Clin Exp Immunol (1989) 0.92
Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice. J Natl Cancer Inst (1976) 0.92
Effects of C-reactive protein on human lymphocyte responsiveness. J Immunol (1983) 0.91
Immunocompetent cells in human testis in health and disease. Fertil Steril (1987) 0.91